BRIEF-CTD Holdings Reports FDA Authorization To Proceed With Single Patient Ind For Use Of Trappsol Cyclo To Treat Alzheimer's Disease
March 12, 2018 at 09:09 AM EDT
* CTD HOLDINGS ANNOUNCES FDA AUTHORIZATION TO PROCEED WITH SINGLE PATIENT IND FOR USE OF TRAPPSOL(R) CYCLO(TM) TO TREAT ALZHEIMER'S DISEASE Source text for Eikon: Further company coverage: